Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222584 | SCV000270772 | likely benign | not specified | 2015-05-17 | criteria provided, single submitter | clinical testing | p.Ser314Ser in exon 7 of PRPS1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 33/87762 of chromoso mes (including 12 hemizygous individuals) by the Exome Aggregation Consortium (E xAC, http://exac.broadinstitute.org; dbSNP rs147731055). |
Eurofins Ntd Llc |
RCV000222584 | SCV000343171 | benign | not specified | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001200509 | SCV000522580 | benign | not provided | 2021-03-26 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19377476) |
Labcorp Genetics |
RCV000474888 | SCV000561871 | benign | Charcot-Marie-Tooth Neuropathy X | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001200509 | SCV001371488 | likely benign | not provided | 2020-04-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004020600 | SCV002683160 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |